Accession 628
Title A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies
Summary The purpose of the present study was to further evaluate the biologic significance of the CD22ΔE12 molecular lesion and determine if it could serve as a molecular target for RNA interference (RNAi) therapy.
Journal EBioMedicine
Publish date December, 2014
Corresponding Author Fatih M. Uckun
Array Type Antibody array
Species Mus musculus
Raw data link


Link to PubMed

PubMed ID:25599086